Ataxia Telangiectasia Mutated Protein Kinase: A Potential Master Puppeteer of Oxidative Stress-Induced Metabolic Recycling

Ataxia Telangiectasia Mutated protein kinase (ATM) has lately come to the fore as a regulatory protein fulfilling many roles within the fantastic balancing act of metabolic homeostasis. Greatest recognized for its position as a transducer of DNA harm restore, the exercise of ATM within the cytosol is having fun with growing consideration, the place it performs a central position typically mobile recycling (macroautophagy) in addition to the focused clearance (selective autophagy) of broken mitochondria and peroxisomes in response to oxidative stress, independently of the DNA harm response.
The significance of ATM activation by oxidative stress has additionally lately been highlighted within the clearance of protein aggregates, the place the expression of a practical ATM assemble that can’t be activated by oxidative stress resulted in widespread accumulation of protein aggregates. This assessment will focus on the position of ATM typically autophagy, mitophagy, and pexophagy in addition to aggrephagy and crosstalk between oxidative stress as an activator of ATM and its potential position as a grasp regulator of those processes.

Mycobacterium tuberculosis Thymidylyltransferase RmlA Is Negatively Regulated by Ser/Thr Protein Kinase PknB

Ser/Thr phosphorylation by serine/threonine protein kinases (STPKs) performs vital roles in molecular regulation, which permits Mycobacteria to adapt their cell wall construction in response to the atmosphere adjustments. Figuring out direct targets of STPKs and figuring out their actions are subsequently important to revealing their perform in Mycobacteria, for instance, in cell wall formation and virulence. Herein, we reported that RmlA, a vital L-rhamnose biosynthesis enzyme, is a substrate of STPK PknB in Mycobacterium tuberculosis (M. tuberculosis).
Mass spectrometry evaluation revealed that RmlA is phosphorylated at Thr-12, Thr-54, Thr-197, and Thr-12 is situated near the catalytic triad of RmlA. Biochemical and phenotypic evaluation of two RmlA mutants, T12A/T12D, confirmed that their actions have been decreased, and cell wall formation was negatively affected. Furthermore, virulence of RmlA T12D mutant was attenuated in a macrophage mannequin. Total, these outcomes present the primary proof for the position of PknB-dependent RmlA phosphorylation in regulating cell wall formation in Mycobacteria, with vital implications for pathogenicity.

BRASSINOSTEROID-SIGNALING KINASE 1 phosphorylating CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE capabilities in drought tolerance in maize

Drought stress critically limits crop productiveness. Though research have been carried out, it’s nonetheless largely unknown that how plant responds to drought stress. Right here we discover that drought remedy can improve the phosphorylation exercise of brassinosteroid-signaling kinase 1 (ZmBSK1) in maize (Zea mays). Our genetic research reveal that ZmBSK1 positively impacts drought tolerance in maize crops. ZmBSK1 localizes in plasma membrane, interacts with calcium/calmodulin-dependent protein kinase (ZmCCaMK), and phosphorylates ZmCCaMK. Ser-67 is an important phosphorylation website of ZmCCaMK by ZmBSK1.
Drought stress enhances not solely the interplay between ZmBSK1 and ZmCCaMK but additionally the phosphorylation of Ser-67 in ZmCCaMK by ZmBSK1. Moreover, Ser-67 phosphorylation in ZmCCaMK regulates its Ca2+ /CaM binding, autophosphorylation exercise and transphosphorylation exercise, and positively impacts its perform in drought tolerance in maize. Our outcomes reveal an essential position of ZmBSK1 in drought tolerance and recommend a direct regulatory mode of ZmBSK1 phosphorylating ZmCCaMK.

Methamphetamine publicity induces neuronal programmed necrosis by activating the receptor-interacting protein kinase 3 -related signalling pathway

Methamphetamine (METH) is an artificial drug with extreme neurotoxicity, nevertheless, the regulation of METH-induced neuronal programmed necrosis stays poorly understood. The goal of this research was to determine the molecular mechanisms of METH-induced neuronal programmed necrosis. We discovered that neuronal programmed necrosis occurred within the striatum of mind samples from human and mice that have been uncovered to METH.
The receptor-interacting protein kinase 3 (RIP3) was extremely expressed within the neurons of human and mice uncovered to METH, and RIP3-silenced or RIP1-inhibited protected neurons developed neuronal programmed necrosis in vitro and in vivo following METH publicity. Furthermore, the RIP1-RIP3 complicated causes cell programmed necrosis by regulating blended lineage kinase domain-like protein (MLKL)-mediated cell membrane rupture and dynamin-related protein 1 (Drp1)-mediated mitochondrial fission. Collectively, these information point out that RIP3 performs an indispensable position within the mechanism of METH-induced neuronal programmed necrosis, which can characterize a possible therapeutic goal for METH-induced neurotoxicity.
Ataxia Telangiectasia Mutated Protein Kinase: A Potential Master Puppeteer of Oxidative Stress-Induced Metabolic Recycling

Pyruvate kinase M2 in persistent inflammations: a potpourri of essential proteinprotein interactions

Power irritation (CI) is a major contributing issue concerned in a number of ailments like most cancers, stroke, diabetes, Alzheimer’s illness, allergy, bronchial asthma, autoimmune ailments, coeliac illness, glomerulonephritis, sepsis, hepatitis, inflammatory bowel illness, reperfusion harm, and transplant rejections. Regardless of a number of expansions in our understanding of inflammatory issues and their mediators, it appears clear that quite a few proteins take part within the onset of CI. One essential protein pyruvate kinase M2 (PKM2) a lot studied in most cancers can be discovered to be inextricably woven within the onset of a number of CI’s. It has been discovered that PKM2 performs a big position in a number of issues utilizing a community of proteins that work together in a number of methods.
As an illustration, PKM2 types an in depth affiliation with epidermal development issue receptors (EGFRs) for uncontrolled development and proliferation of tumor cells. In neurodegeneration, PKM2 interacts with apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) to onset Alzheimer’s illness pathogenesis. The cross-talk of protein tyrosine phosphatase 1B (PTP1B) and PKM2 acts as stepping stones for the graduation of diabetes. Maybe PKM2 shops the potential to unlock the pathophysiology of a number of ailments.

Recombinant Human NQO1 Protein, His, E.coli-2ug

QP12875-2ug 2ug
EUR 186

Recombinant Human NQO1 Protein, His, E.coli-10ug

QP12875-10ug 10ug
EUR 241.2

Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein

20-abx167110
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein

abx167110-100g 100 µg
EUR 587.5

Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein

abx167110-10g 10 µg
EUR 225

Human NADH Dehydrogenase, Quinone 1 (NQO1) Protein

abx167110-50g 50 µg
EUR 400

NQO1 protein (His tag)

80R-1197 100 ug
EUR 622
Description: Purified recombinant Human NQO1 protein

OPPA02018-2UG - NQO1 Protein

OPPA02018-2UG 2ug
EUR 70

Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein

abx073766-100tests 100 tests
EUR 225

Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein

abx073766-1920tests 1920 tests
EUR 6575

Human NAD(P)H Dehydrogenase [quinone] 1 (NQO1) Protein

abx073766-400tests 400 tests
EUR 325

Recombinant Human NQO1/DT-diaphorase Protein (His Tag)

PKSH030925-50ug 50ug
EUR 867
Description: Human

Human NQO1 Antibody

32959-05111 150 ug
EUR 215

NQO1 Recombinant Protein (Rat)

RP214418 100 ug Ask for price

NQO1 Recombinant Protein (Mouse)

RP154820 100 ug Ask for price

OCOA17845-20UG - NQO1 Protein Lysate

OCOA17845-20UG 20ug
EUR 169

OCOA16065-20UG - NQO1 Protein Lysate

OCOA16065-20UG 20ug
EUR 169

OCOA00288-20UG - NQO1 Protein Lysate

OCOA00288-20UG 20ug
EUR 169

anti- NQO1 antibody

FNab05830 100µg
EUR 606.3
Description: Antibody raised against NQO1

NQO1 Protein Vector (Rat) (pPM-C-HA)

PV285896 500 ng
EUR 723.6

OPCA03267-20UG - Nqo1 Recombinant Protein

OPCA03267-20UG 20ug
EUR 379

OPCD05779-10UG - NQO1 Recombinant Protein

OPCD05779-10UG 10ug
EUR 149

OPCD05779-50UG - NQO1 Recombinant Protein

OPCD05779-50UG 50ug
EUR 369

OPCD05780-10UG - NQO1 Recombinant Protein

OPCD05780-10UG 10ug
EUR 149

OPCD05780-50UG - NQO1 Recombinant Protein

OPCD05780-50UG 50ug
EUR 379

OPCD05781-10UG - NQO1 Recombinant Protein

OPCD05781-10UG 10ug
EUR 139

OPCD05781-50UG - NQO1 Recombinant Protein

OPCD05781-50UG 50ug
EUR 349

NQO1 Protein Vector (Rat) (pPB-C-His)

PV285894 500 ng
EUR 723.6

NQO1 Protein Vector (Rat) (pPB-N-His)

PV285895 500 ng
EUR 723.6

NQO1 Protein Vector (Rat) (pPM-C-His)

PV285897 500 ng
EUR 723.6

NQO1 NAD(P)H Dehydrogenase Quinone 1 Human Recombinant Protein

PROTP15559 Regular: 10ug
EUR 380.4
Description: NQO1 Human Recombinant fused with a 20 amino acids His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 294 amino acids (1-274 a.a.) and having a molecular mass of 33kDa.;The NQO1 is purified by proprietary chromatographic techniques.

OPCA03267-100UG - Nqo1 Recombinant Protein

OPCA03267-100UG 100ug
EUR 555

OPCA03267-500UG - Nqo1 Recombinant Protein

OPCA03267-500UG 500ug
EUR 1534

OPCD05779-200UG - NQO1 Recombinant Protein

OPCD05779-200UG 200ug
EUR 729

OPCD05780-200UG - NQO1 Recombinant Protein

OPCD05780-200UG 200ug
EUR 749

OPCD05781-200UG - NQO1 Recombinant Protein

OPCD05781-200UG 200ug
EUR 699

NQO1 Protein Vector (Mouse) (pPM-C-HA)

PV206432 500 ng
EUR 723.6

Rabbit Anti Human NQO1 Monoclonal Clone AAOB-14

IRBAHUNQO1AAOB14C100UL each
EUR 496
Description: Rabbit Anti Human NQO1 Monoclonal Clone AAOB-14

NQO1 Protein Vector (Mouse) (pPB-C-His)

PV206430 500 ng
EUR 723.6

NQO1 Protein Vector (Mouse) (pPB-N-His)

PV206431 500 ng
EUR 723.6

NQO1 Protein Vector (Mouse) (pPM-C-His)

PV206433 500 ng
EUR 723.6

Mouse Monoclonal anti-human NQO1

hAP-0641 50ug
EUR 400

NQO1, human recombinant

7571-10 each
EUR 392.4

NQO1, human recombinant

7571-50 each
EUR 1123.2

Rat NADH Dehydrogenase, Quinone 1 (NQO1) Protein

20-abx650803
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Rat NADH Dehydrogenase, Quinone 1 (NQO1) Protein

abx650803-5mg 5 mg
EUR 412.5

Mouse NADH Dehydrogenase, Quinone 1 (NQO1) Protein

20-abx168462
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse NADH Dehydrogenase, Quinone 1 (NQO1) Protein

abx168462-1ml 1 ml
EUR 237.5

Human NQO1 ELISA Kit

ELA-E2154h 96 Tests
EUR 988.8

Human NQO1 Antibody (Biotin Conjugate)

32959-05121 150 ug
EUR 315

Human NQO1 shRNA Plasmid

20-abx951197
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

NQO1 ELISA KIT|Human

EF006205 96 Tests
EUR 826.8

Human NQO1 knockout cell line

ABC-KH10291 1 vial Ask for price
Description: Human NQO1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

Nqo1/ Rat Nqo1 ELISA Kit

ELI-06921r 96 Tests
EUR 1063.2

Human NQO1 knockdown cell line

ABC-KD10291 1 vial Ask for price
Description: Human NQO1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

NQO1 ORF Vector (Human) (pORF)

ORF026247 1.0 ug DNA
EUR 114

NQO1 Antibody

32295 100ul
EUR 439

NQO1 Antibody

32295-100ul 100ul
EUR 302.4

NQO1 antibody

22937 100ul
EUR 479

NQO1 antibody

22937-100ul 100ul
EUR 468

NQO1 Antibody

31283 100ul
EUR 319

NQO1 Antibody

31283-100ul 100ul
EUR 302.4

NQO1 Antibody

31283-50ul 50ul
EUR 224.4

NQO1 Antibody

35365 100ul
EUR 479

NQO1 Antibody

35365-100ul 100ul
EUR 468

NQO1 Antibody

1-CSB-PA016039GA01HU
  • Ask for price
  • Ask for price
  • 150ul
  • 50ul
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF

NQO1 Antibody

1-CSB-PA016039LA01HU
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

NQO1 Antibody

E031283 100μg/100μl
EUR 255
Description: Available in various conjugation types.

NQO1 Antibody

F50335-0.08ML 0.08 ml
EUR 140.25
Description: NQO1 is a member of the NAD(P)H dehydrogenase(quinone) family and a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Altered expression of the protein has been seen in many tumors and is also associated with Alzheimer's disease (AD).

NQO1 Antibody

F50335-0.4ML 0.4 ml
EUR 322.15
Description: NQO1 is a member of the NAD(P)H dehydrogenase(quinone) family and a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Altered expression of the protein has been seen in many tumors and is also associated with Alzheimer's disease (AD).

NQO1 Antibody

E38PA1342 100ul
EUR 225
Description: Available in various conjugation types.

NQO1 Antibody

E314247 100ug/200ul
EUR 295
Description: Available in various conjugation types.

NQO1 Antibody

E91518 100ul
EUR 255
Description: Available in various conjugation types.

NQO1 Antibody

DF6437 200ul
EUR 420

NQO1 Antibody

DF6437-100ul 100ul
EUR 280

NQO1 Antibody

DF6437-200ul 200ul
EUR 350

NQO1 Antibody

1-CSB-PA003475
  • Ask for price
  • Ask for price
  • 100ug
  • 50ug
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

NQO1 Antibody

3639-100 each
EUR 418.8

NQO1 Antibody

3639-30T each
EUR 175.2

NQO1 Antibody

49364 100ul
EUR 499

NQO1 Antibody

49364-100ul 100ul
EUR 399.6

NQO1 Antibody

49364-50ul 50ul
EUR 286.8

NQO1 antibody

70R-18946 50 ul
EUR 289
Description: Rabbit polyclonal NQO1 antibody

NQO1 antibody

70R-49661 100 ul
EUR 242
Description: Purified Polyclonal NQO1 antibody

NQO1 antibody

70R-10256 50 ug
EUR 467
Description: Affinity purified rabbit polyclonal NQO1 antibody

NQO1 antibody

70R-10257 50 ug
EUR 467
Description: Affinity purified rabbit polyclonal NQO1 antibody

NQO1 antibody

70R-12504 100 ul
EUR 550
Description: Affinity purified Rabbit polyclonal NQO1 antibody

NQO1 Antibody

ABD6437 100 ug
EUR 525.6

NQO1 Antibody

1-CSB-PA102829
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100

NQO1 Antibody

1-CSB-PA890070
  • Ask for price
  • Ask for price
  • 100ul
  • 50ul
Description: A polyclonal antibody against NQO1. Recognizes NQO1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:10000, WB:1:500-1:2000, IHC:1:50-1:200

NQO1 Antibody

RQ5489 100 ul
EUR 356.15
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [RefSeq]

NQO1 Antibody

GWB-E9E683 0.1 mg Ask for price

NQO1 Antibody

GWB-MW183C 50ug Ask for price

NQO1 Antibody

GWB-MW184D 50ug Ask for price

NQO1 Antibody

R31977 100 ug
EUR 356.15
Description: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. And this FAD-binding protein forms homodimers and reduces quinones to hydroquinones. In addition, this protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

NQO1 Antibody

R35927-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: NAD(P)H dehydrogenase, quinone 1

NQO1 Antibody

R33500-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: NAD(P)H dehydrogenase, quinone 1

NQO1 Antibody

N1103-100UG 100 ug
EUR 356.15
Description: NAD(P)H:quinone oxidoreductase is an enzyme that catalyzes the two-electron reduction of quinones to hydroquinones, resulting in the activation or deactivation of the hydroquinone. Increased expression of NQO1 is seen in tumors of the breast, liver and colon and NSCLC (non-small cell lung cancer), suggesting a role in tumor development and possibly treatment. NQO1 has also been linked to Alzheimer's disease, found to be upregulated in response to the oxidative stress of the AD process.

NQO1 Antibody

N1103-25UG 25 ug
EUR 177.65
Description: NAD(P)H:quinone oxidoreductase is an enzyme that catalyzes the two-electron reduction of quinones to hydroquinones, resulting in the activation or deactivation of the hydroquinone. Increased expression of NQO1 is seen in tumors of the breast, liver and colon and NSCLC (non-small cell lung cancer), suggesting a role in tumor development and possibly treatment. NQO1 has also been linked to Alzheimer's disease, found to be upregulated in response to the oxidative stress of the AD process.

NQO1

enz-448 2µg
EUR 60
Description: Recombinant Human NAD(P)H Dehydrogenase Quinone 1

NQO1

E8EM1801-21 100ul
EUR 275
Description: Available in various conjugation types.

NQO1

E8ER1802-85 100ul
EUR 275
Description: Available in various conjugation types.

NQO1

E8ET1702-50 100ul
EUR 275
Description: Available in various conjugation types.

NQO1 ELISA Kit (Human) (OKCD09345)

OKCD09345 96 Wells
EUR 1090.8
Description: Description of target: This gene is a member of the NAD(P)H dehydrogenase (quinone) family and encodes a cytoplasmic 2-electron reductase. This FAD-binding protein forms homodimers and reduces quinones to hydroquinones. This protein's enzymatic activity prevents the one electron reduction of quinones that results in the production of radical species. Mutations in this gene have been associated with tardive dyskinesia (TD), an increased risk of hematotoxicity after exposure to benzene, and susceptibility to various forms of cancer. Altered expression of this protein has been seen in many tumors and is also associated with Alzheimer's disease (AD). Alternate transcriptional splice variants, encoding different isoforms, have been characterized.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.122ng/mL

NQO1 (human intracellular) ELISA Kit

GWB-AXR261 100 assays Ask for price

Human Intracellular NQO1 ELISA Kit

LF-EK70031 1×96T
EUR 722.4

NQO1 (human intracellular) ELISA Kit

K4926-100 each
EUR 1149.6

Human NQO1 AssayLite™ Antibody (RPE Conjugate)

32959-05151 150 ug
EUR 370

Human NQO1 AssayLite™ Antibody (APC Conjugate)

32959-05161 150 ug
EUR 370

Human NQO1 AssayLite™ Antibody (FITC Conjugate)

32959-05141 150 ug
EUR 370

Human NQO1 AssayLite™ Antibody (PerCP Conjugate)

32959-05171 150 ug
EUR 410

NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 1

SC119599 10 µg Ask for price

NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 2

SC302402 10 µg Ask for price

NQO1 (untagged)-Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 3

SC302403 10 µg Ask for price

NQO1 (untagged) - Human NAD(P)H dehydrogenase, quinone 1 (NQO1), transcript variant 4

SC334423 10 µg Ask for price

NQO1 Antibody (HRP)

GWB-DE08BC 0.1 mg Ask for price
Right here we offer an summary of the notoriously convoluted biology of CI’s and PKM2. The cross-talk of PKM2 with a number of proteins concerned in stroke, Alzheimer’s, most cancers, and different ailments has additionally been mentioned. We consider that contemplating the significance of PKM2 in inflammation-related ailments, new choices for treating numerous issues with the event of extra selective brokers concentrating on PKM2 could seem.

Leave a Reply

Your email address will not be published. Required fields are marked *